An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organismJerod L. Ptacin, Marcos E. Milla|Nature Communications|2021Cited by 117
A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organismJerod L. Ptacin, Marcos E. Milla|Communications Medicine|2024Cited by 5